CYP4B1
Basic information
Region (hg38): 1:46757838-46819413
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP4B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 33 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 33 | 4 | 9 |
Variants in CYP4B1
This is a list of pathogenic ClinVar variants found in the CYP4B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-46799094-T-A | Benign (Jun 29, 2018) | |||
1-46799124-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
1-46799208-A-C | not specified | Uncertain significance (Jul 27, 2022) | ||
1-46799228-T-C | Benign/Likely benign (Feb 01, 2023) | |||
1-46799251-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
1-46810818-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
1-46810830-A-G | not specified | Uncertain significance (Jun 22, 2023) | ||
1-46810881-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
1-46810883-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
1-46810914-A-G | not specified | Uncertain significance (Oct 10, 2023) | ||
1-46810943-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
1-46811147-G-A | Benign (Jul 16, 2018) | |||
1-46811158-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
1-46812541-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
1-46812586-A-T | not specified | Uncertain significance (Feb 28, 2024) | ||
1-46812612-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
1-46813492-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
1-46813516-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
1-46814021-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
1-46814022-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
1-46814027-T-C | Likely benign (May 31, 2018) | |||
1-46814226-C-T | Benign (Jun 13, 2018) | |||
1-46814237-C-G | Likely benign (Jul 12, 2018) | |||
1-46814274-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
1-46814275-G-A | not specified | Uncertain significance (Aug 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP4B1 | protein_coding | protein_coding | ENST00000371923 | 12 | 61576 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.28e-10 | 0.508 | 91211 | 2955 | 31582 | 125748 | 0.148 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.208 | 312 | 302 | 1.03 | 0.0000175 | 3373 |
Missense in Polyphen | 95 | 94.889 | 1.0012 | 1155 | ||
Synonymous | -0.398 | 119 | 114 | 1.05 | 0.00000587 | 984 |
Loss of Function | 1.19 | 18 | 24.3 | 0.740 | 0.00000104 | 274 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.252 | 0.252 |
Ashkenazi Jewish | 0.126 | 0.125 |
East Asian | 0.243 | 0.240 |
Finnish | 0.142 | 0.142 |
European (Non-Finnish) | 0.143 | 0.142 |
Middle Eastern | 0.243 | 0.240 |
South Asian | 0.134 | 0.133 |
Other | 0.145 | 0.146 |
dbNSFP
Source:
- Function
- FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.;
- Pathway
- Nuclear Receptors in Lipid Metabolism and Toxicity;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Tyrosine metabolism;Fatty acids;Eicosanoids;Androgen and estrogen biosynthesis and metabolism;Miscellaneous substrates;Cytochrome P450 - arranged by substrate type;Leukotriene metabolism;Biological oxidations;Metabolism;Fatty acid metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;Tryptophan degradation;Arachidonic acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.242
Intolerance Scores
- loftool
- 0.455
- rvis_EVS
- 2.13
- rvis_percentile_EVS
- 97.95
Haploinsufficiency Scores
- pHI
- 0.0688
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0901
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Cyp4b1
- Phenotype
- homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- biphenyl metabolic process;fluorene metabolic process;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- endoplasmic reticulum membrane;organelle membrane
- Molecular function
- monooxygenase activity;iron ion binding;toxic substance binding;fluorene oxygenase activity;oxygen binding;heme binding;aromatase activity